Evidence map›Paper›PMID 35575289›Full record

ArticleJournal of medical virology2022

In silico analysis of mutations near S1/S2 cleavage site in SARS-CoV-2 spike protein reveals increased propensity of glycosylation in Omicron strain.

Christopher A Beaudoin, Arun P Pandurangan, So Yeon Kim, Samir W Hamaia, Christopher L-H Huang, Tom L Blundell, Sundeep Chaitanya Vedithi, Antony P Jackson

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. The Binding of Brazilin fromInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Structural proteins of human coronaviruses: what makes them different?Frontiers in cellular and infection microbiology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Christopher A BeaudoinDepartment of Biochemistry, Sanger Building, University of Cambridge, Cambridge, United Kingdom.
Arun P PanduranganDepartment of Biochemistry, Sanger Building, University of Cambridge, Cambridge, United Kingdom.
So Yeon KimDepartment of Biochemistry, Sanger Building, University of Cambridge, Cambridge, United Kingdom.
Samir W HamaiaDepartment of Biochemistry, Hopkins Building, University of Cambridge, Cambridge, United Kingdom.
Christopher L-H HuangDepartment of Biochemistry, Hopkins Building, University of Cambridge, Cambridge, United Kingdom.
Tom L BlundellDepartment of Biochemistry, Sanger Building, University of Cambridge, Cambridge, United Kingdom.
Sundeep Chaitanya VedithiDepartment of Biochemistry, Sanger Building, University of Cambridge, Cambridge, United Kingdom.
Antony P JacksonDepartment of Biochemistry, Hopkins Building, University of Cambridge, Cambridge, United Kingdom.
University of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cleavage of the severe respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein has been demonstrated to contribute to viral-cell fusion and syncytia formation. Studies have shown that variants of concern (VOC) and variants of interest (VOI) show differing membrane fusion capacity. Mutations near cleavage motifs, such as the S1/S2 and S2' sites, may alter interactions with host proteases and, thus, the potential for fusion. The biochemical basis for the differences in interactions with host proteases for the VOC/VOI spike proteins has not yet been explored. Using sequence and structure-based bioinformatics, mutations near the VOC/VOI spike protein cleavage sites were inspected for their structural effects. All mutations found at the S1/S2 sites were predicted to increase affinity to the furin protease but not TMPRSS2. Mutations at the spike residue P681 in several strains, such P681R in the Delta strain, resulted in the disruption of a proline-directed kinase phosphorylation motif at the S1/S2 site, which may lessen the impact of phosphorylation for these variants. However, the unique N679K mutation in the Omicron strain was found to increase the propensity for O-linked glycosylation at the S1/S2 cleavage site, which may prevent recognition by proteases. Such glycosylation in the Omicron strain may hinder entry at the cell surface and, thus, decrease syncytia formation and induce cell entry through the endocytic pathway as has been shown in previous studies. Further experimental work is needed to confirm the effect of mutations and posttranslational modifications on SARS-CoV-2 spike protein cleavage sites.

Indexed as

SARS-CoV-2Spike Glycoprotein, CoronavirusGlycosylationMutationSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Delta variantfurinO-linked glycosylationOmicron variantSARS-CoV-2 spike proteinTMPRSS2

Identifiers

PMID35575289
PMCPMC9348480
OpenAlexW4280583684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.